Search research articles
Contact Us
Filters
Showing results (101-110 of 351) with videos related to
Page
of 36
Sort By:
Cancer Treatment Reviews
|
May 27, 2011
Minimal residual disease in solid neoplasia: New frontier or red-herring?
Pierre Mordant, Yohann Loriot, Benoît Lahon, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2017
Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
Roger Sun, Francois-Xavier Danlos, Samy Ammari, et al.
Anti-Cancer Drugs
|
May 24, 2013
The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts
Mélanie Deberne, Antonin Levy, Michele Mondini, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination
Pierre Mordant, Yohann Loriot, Céline Leteur, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2013
Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough?
Tony Sourisseau, Khaled A Hassan, Ignacio Wistuba, et al.
Head & Neck
|
May 15, 2015
Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer
Antonin Levy, Francesca De Felice, Sara Bellefqih, et al.
Cancer Biology & Therapy
|
September 14, 2006
Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines
Keith A Cengel, Eric Deutsch, Trevor C Stephens, et al.
Frontiers in Oncology
|
December 14, 2020
Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow
Roger Sun, Samy Ammari, Sophie Bockel, et al.
Cancer Letters
|
September 23, 2011
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts
Cyrus Chargari, Celine Leteur, Eric Angevin, et al.
Cancer Immunology Research
|
September 26, 2024
Deleting Trim33 in Myeloid Cells Improves the Efficiency of Radiotherapy through an IFNβ-Dependent Antitumor Immune Response
Anaïs Assouvie, Marine Gerbé-de-Thoré, Claire Torres, et al.
Page
of 36
Search research articles
Search
Showing results (101-110 of 351) with videos related to
Sort By:
Page
of 36
Cancer Treatment Reviews
|
May 27, 2011
Minimal residual disease in solid neoplasia: New frontier or red-herring?
Pierre Mordant, Yohann Loriot, Benoît Lahon, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2017
Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
Roger Sun, Francois-Xavier Danlos, Samy Ammari, et al.
Anti-Cancer Drugs
|
May 24, 2013
The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts
Mélanie Deberne, Antonin Levy, Michele Mondini, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination
Pierre Mordant, Yohann Loriot, Céline Leteur, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 19, 2013
Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough?
Tony Sourisseau, Khaled A Hassan, Ignacio Wistuba, et al.
Head & Neck
|
May 15, 2015
Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer
Antonin Levy, Francesca De Felice, Sara Bellefqih, et al.
Cancer Biology & Therapy
|
September 14, 2006
Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines
Keith A Cengel, Eric Deutsch, Trevor C Stephens, et al.
Frontiers in Oncology
|
December 14, 2020
Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow
Roger Sun, Samy Ammari, Sophie Bockel, et al.
Cancer Letters
|
September 23, 2011
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts
Cyrus Chargari, Celine Leteur, Eric Angevin, et al.
Cancer Immunology Research
|
September 26, 2024
Deleting Trim33 in Myeloid Cells Improves the Efficiency of Radiotherapy through an IFNβ-Dependent Antitumor Immune Response
Anaïs Assouvie, Marine Gerbé-de-Thoré, Claire Torres, et al.
Page
of 36